*Department of Surgery, Mayo Clinic, Rochester, Minnesota; and †Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.
Inflamm Bowel Dis. 2017 Dec;23(12):2142-2146. doi: 10.1097/MIB.0000000000001238.
Ileal pouch-anal anastomosis (IPAA) is the preferred surgical treatment for patients with chronic ulcerative colitis. Little is known about the impact of obesity on operative characteristics, short-term postoperative complications and long-term functional outcomes after IPAA.
A retrospective review of all patients undergoing IPAA for chronic ulcerative colitis at a single tertiary referral center between January 2002 and August 2013 was performed. Thirty-day postoperative complications and long-term functional outcomes were analyzed according to body mass index.
Nine hundred nine IPAAs (154 obese [body mass index ≥ 30] and 755 not obese [body mass index < 30]) were performed during the study period. For 2-stage IPAA, obese patients were less likely to undergo laparoscopic IPAA (P < 0.0001), had greater estimated blood loss (P = 0.005), and longer operative times (P = 0.02). For 3-stage IPAA, obese patients were less likely to undergo a laparoscopic procedure (P = 0.03), had greater estimated blood loss (P < 0.0001), and longer operative times (P = 0.0002). Postoperatively, obese patients had a longer length of stay after a 2-stage procedure (P = 0.009), an increased rate of superficial surgical site infections (P = 0.003), and an increased rate of urinary tract infections (P = 0.03). Of the 61% (n = 546) of patients with IPAA with long-term (median 5.0 years) follow-up, there were no significant differences in functional outcomes including incontinence, frequency of bowel movements, pad usage, and pouchitis between the groups.
Obesity impacts intraoperative complexity and 30-day postoperative outcomes. Long-term functional outcomes are not affected. These findings underscore the need to counsel patients on preoperative weight loss before undergoing elective IPAA.
回肠储袋肛管吻合术(IPAA)是治疗慢性溃疡性结肠炎患者的首选手术方法。对于肥胖对 IPAA 手术特点、短期术后并发症和长期功能结果的影响知之甚少。
对 2002 年 1 月至 2013 年 8 月期间在一家三级转诊中心接受 IPAA 治疗慢性溃疡性结肠炎的所有患者进行回顾性分析。根据体重指数分析 30 天术后并发症和长期功能结果。
研究期间共进行了 909 例 IPAA(154 例肥胖[体重指数≥30]和 755 例不肥胖[体重指数<30])。对于 2 期 IPAA,肥胖患者更不可能接受腹腔镜 IPAA(P<0.0001),出血量更多(P=0.005),手术时间更长(P=0.02)。对于 3 期 IPAA,肥胖患者更不可能接受腹腔镜手术(P=0.03),出血量更多(P<0.0001),手术时间更长(P=0.0002)。术后,2 期手术肥胖患者的住院时间更长(P=0.009),浅表手术部位感染发生率更高(P=0.003),尿路感染发生率更高(P=0.03)。在接受 IPAA 治疗的 61%(n=546)的患者中,有长期(中位 5.0 年)随访结果,两组之间的功能结果(包括失禁、排便频率、使用护垫和储袋炎)没有显著差异。
肥胖会影响手术中的复杂性和 30 天术后结果。长期功能结果不受影响。这些发现强调了在择期接受 IPAA 之前,需要对患者进行术前减肥咨询。